Precision Biosciences' ARCUS platform offers high precision and versatility, supporting in vivo gene editing therapies, and ...

Hepatitis B virus (HBV) infection remains an urgent global health concern, affecting hundreds of millions of people and significantly heightening the risk ...

Hepatitis B virus (HBV) is the leading cause of cirrhosis, hepatocellular carcinoma, and liver-related death globally.1,2 The highest prevalence is found in low-income and middle-income countries ...

Officials and the media team in a group photograph Consultant Gastroenterologist, University of Ghana Medical Centre, Dr. Amoako Duah, has reiterated that viral hepatitis remains a major public health ...

Hepatitis B can lead to liver disease. But we can prevent and manage this viral infection. Here’s what we know about the ...

Gilead's CROI 2025 data highlights Biktarvy's sustained HIV/HBV suppression, lenacapavir's efficacy, and vesatolimod's safety ...

Immunocore presents initial multiple ascending dose data for HIV functional cure candidate in an oral presentation at CROI 2025IMC-M113V was well ...

The following is a summary of "Impact of HBsAg reduction via siRNA treatment on natural and vaccine (BRII-179)-induced ...

Chronic hepatitis B (CHB) remains a major global health challenge, with functional cure achieved in only a small subset of patients. Current oral antiviral agents effectively suppress viral ...

Scientists discovered a way to block hepatitis B infection using an anticancer drug, offering hope for new treatments.

The American Gastroenterological Association (AGA) has released an updated clinical practice guideline on the prevention of ...

There's a vaccine to prevent HBV, but not HCV. Those with higher chances ... and post-exposure prophylaxis (PEP). While there's no cure, you can control HIV with treatment. About 2% to 5% of ...